278 related articles for article (PubMed ID: 31763809)
1. Oxygen-Self-Supplying and HIF-1α-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy.
Liu P; Xie X; Shi X; Peng Y; Ding J; Zhou W
ACS Appl Mater Interfaces; 2019 Dec; 11(51):48261-48270. PubMed ID: 31763809
[TBL] [Abstract][Full Text] [Related]
2. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
3. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
4. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
6. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
[TBL] [Abstract][Full Text] [Related]
8. Self-Remedied Nanomedicine for Surmounting the Achilles' Heel of Photodynamic Tumor Therapy.
Zhou X; Huang JQ; Liu LS; Deng FA; Liu YB; Li YM; Chen AL; Yu XY; Li SY; Cheng H
ACS Appl Bio Mater; 2021 Nov; 4(11):8023-8032. PubMed ID: 35006783
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
He Z; Dai Y; Li X; Guo D; Liu Y; Huang X; Jiang J; Wang S; Zhu G; Zhang F; Lin L; Zhu JJ; Yu G; Chen X
Small; 2019 Jan; 15(4):e1804131. PubMed ID: 30565431
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
11. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
12. Catalytic nanographene oxide with hemin for enhanced photodynamic therapy.
Sahu A; Min K; Jeon J; Yang HS; Tae G
J Control Release; 2020 Oct; 326():442-454. PubMed ID: 32726649
[TBL] [Abstract][Full Text] [Related]
13. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
[TBL] [Abstract][Full Text] [Related]
14. Self-Assembly Catalase Nanocomplex Conveyed by Bacterial Vesicles for Oxygenated Photodynamic Therapy and Tumor Immunotherapy.
Zhang J; Li Z; Liu L; Li L; Zhang L; Wang Y; Zhao J
Int J Nanomedicine; 2022; 17():1971-1985. PubMed ID: 35530972
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha.
Mitra S; Cassar SE; Niles DJ; Puskas JA; Frelinger JG; Foster TH
Mol Cancer Ther; 2006 Dec; 5(12):3268-74. PubMed ID: 17172430
[TBL] [Abstract][Full Text] [Related]
16. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
17. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin as a "One-Stone-Three-Birds" Agent for Cooperatively Enhanced Phototherapies Against Metastatic Breast Cancer.
Liu P; Peng Y; Zhou Y; Shi X; Li Q; Ding J; Gao Y; Zhou W
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25674-25684. PubMed ID: 34042422
[TBL] [Abstract][Full Text] [Related]
19. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
[TBL] [Abstract][Full Text] [Related]
20. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells.
Rodríguez ME; Catrinacio C; Ropolo A; Rivarola VA; Vaccaro MI
Photochem Photobiol Sci; 2017 Nov; 16(11):1631-1642. PubMed ID: 28936522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
